Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

The global specialty generics market reached a value of US$ 57.3 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 11.1% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don’t require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global specialty generics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Italy
    • Germany
    • Spain
    • United Kingdom
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa


Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others


Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others


Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies


Competitive Landscape:

The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

IMARC Group’s latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Route of Administration, Indication, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Brazil, Mexico
Companies Covered Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp. and Endo International plc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Global Specialty Generics Market: Introduction
5    Why are Specialty Generics So Lucrative?
6    Global Specialty Generics Market

    6.1    Market Overview
    6.2    Market Performance
    6.3    Impact of COVID-19
    6.4    Market Breakup by Route of Administration
    6.5    Market Breakup by Indication
    6.6    Market Breakup by Distribution Channel
    6.7    Market Breakup by Region
    6.8    Market Forecast
    6.9    SWOT Analysis
        6.9.1    Overview
        6.9.2    Strengths
        6.9.3    Weaknesses
        6.9.4    Opportunities
        6.9.5    Threats
    6.10    Value Chain Analysis
    6.11    Porters Five Forces Analysis
        6.11.1    Overview
        6.11.2    Bargaining Power of Buyers
        6.11.3    Bargaining Power of Suppliers
        6.11.4    Degree of Competition
        6.11.5    Threat of New Entrants
        6.11.6    Threat of Substitutes
    6.12    Key Market Drivers and Success Factors
7    Market Breakup by Route of Administration
    7.1    Injectable
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Oral
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Others
        7.3.1    Market Trends
        7.3.2    Market Forecast
8    Market Breakup by Indication
    8.1    Oncology
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Autoimmune Diseases
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Infectious Diseases
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Others
        8.4.1    Market Trends
        8.4.2    Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Specialty Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Hospital Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1    Market Overview
        10.1.2    Market Performance
        10.1.3    Market Breakup by Country
        10.1.4    United States
            10.1.4.1    Market Trends
            10.1.4.2    Market Forecast
        10.1.5    Canada
            10.1.5.1    Market Trends
            10.1.5.2    Market Forecast
    10.2    Europe
        10.2.1    Market Overview
        10.2.2    Market Performance
        10.2.3    Market Breakup by Country
        10.2.4    Italy
            10.2.4.1    Market Trends
            10.2.4.2    Market Forecast
        10.2.5    Germany
            10.2.5.1    Market Trends
            10.2.5.2    Market Forecast
        10.2.6    France
            10.2.6.1    Market Trends
            10.2.6.2    Market Forecast
        10.2.7    United Kingdom
            10.2.7.1    Market Trends
            10.2.7.2    Market Forecast
        10.2.8    Spain
            10.2.8.1    Market Trends
            10.2.8.2    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Overview
        10.3.2    Market Performance
        10.3.3    Market Breakup by Country
        10.3.4    Japan
            10.3.4.1    Market Trends
            10.3.4.2    Market Forecast
        10.3.5    China
            10.3.5.1    Market Trends
            10.3.5.2    Market Forecast
        10.3.6    India
            10.3.6.1    Market Trends
            10.3.6.2    Market Forecast
        10.3.7    South Korea
            10.3.7.1    Market Trends
            10.3.7.2    Market Forecast
    10.4    Latin America
        10.4.1    Market Overview
        10.4.2    Market Performance
        10.4.3    Market Breakup by Country
        10.4.4    Brazil
            10.4.4.1    Market Trends
            10.4.4.2    Market Forecast
        10.4.5    Mexico
            10.4.5.1    Market Trends
            10.4.5.2    Market Forecast
    10.5    Middle East and Africa
        10.5.1    Market Overview
        10.5.2    Market Performance
        10.5.3    Market Forecast
11    Competitive Landscape
    11.1    Market Structure
    11.2    Key Players
    11.3    Profiles of Key Players
        11.3.1    Teva Pharmaceuticals Industries
        11.3.2    Akorn, Inc.
        11.3.3    Mylan N.V.
        11.3.4    Mallinckrodt
        11.3.5    Sandoz International GmbH
        11.3.6    Pfizer, Inc.
        11.3.7    Sun Pharmaceutical Industries Ltd.
        11.3.8    Valeant Pharmaceuticals
        11.3.9    Apotex Corp.
        11.3.10    Endo International plc. 

List of Figures

Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2020
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: Global: Specialty Generics Industry: SWOT Analysis
Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
Figure 9: Global: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2015 & 2020
Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2015 & 2020
Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2015 & 2020
Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2015 & 2020
Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2015 & 2020
Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2015 & 2020
Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2015 & 2020
Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2015 & 2020
Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2021-2026
Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2015 & 2020
Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2021-2026
Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2015 & 2020
Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2021-2026
Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2021-2026
Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2021-2026
Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2021-2026
Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2021-2026
Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 11: Global: Specialty Generics Market Structure
Table 12: Global: Specialty Generics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

The global specialty generics market was valued at US$ 57.3 Billion in 2020.

The increasing prevalence of numerous life-threatening diseases, such as cancer, multiple sclerosis, HIV, etc., is primarily catalyzing the global specialty generics market.

Sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across several nations resulting in delayed R&D activities pertaining to specialty generics.

Based on the route of administration, the global specialty generics market can be segregated into injectables, oral, and others. Among these, injectables hold the majority of the total market share.

Based on the indication, the global specialty generics market has been bifurcated into oncology, autoimmune diseases, infectious diseases, and others. Currently, oncology diseases exhibit a clear dominance in the market.

Based on the distribution channel, the global specialty generics market can be categorized into retail pharmacies, specialty pharmacies, and hospital pharmacies. Among these, specialty pharmacies currently account for the majority of the total market share.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market. 

Some of the major players in the global specialty generics market include Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links